Anupam Rasayan India Limited (ANURAS.NS) Bundle
Anupam Rasayan India Limited, established in 1984 and backed by over 40 years of specialty-chemicals expertise, operates six manufacturing sites with a combined installed capacity of more than 30,000 metric tonnes per annum, produces a portfolio of over 60 complex molecules and 30 commercial chemistries, and supports innovation through DSIR recognition and a research team of more than 90 scientists - all fueling a mission to be the partner of choice for sustainable, integrated specialty-chemistry solutions; its vision targets 20% annual revenue growth, a 10% market-share increase by 2025, and a 30% carbon-emissions reduction by 2025, backed by strategic investments including a ₹10 crore CRM rollout and ₹20 crore in employee training for 2024, while core values of integrity, safety (zero accidents), diversity (aiming to raise female workforce participation by 1.5-2% by 2027), environmental stewardship (net‑zero energy by 2027 and fresh-water reduction of 5-10% by 2030), and adherence to GRI/UNSDG governance unify its growth, sustainability and customer-centric ambitions.
Anupam Rasayan India Limited (ANURAS.NS) - Intro
Anupam Rasayan India Limited is a leading specialty chemicals manufacturer in India, specializing in custom synthesis and production of specialty chemicals for life sciences and performance materials. Established in 1984, the company leverages over four decades of domain expertise to serve a diverse global clientele across agrochemicals, personal care, pharmaceuticals, electronic chemicals and polymers.- Founded: 1984 - over 40 years of operations
- Primary focus: Custom synthesis, contract manufacturing and commercial supply of specialty and complex molecules
- Listed: NSE ticker ANURAS.NS
| Metric | Value / Notes |
|---|---|
| Manufacturing footprint | 6 sites (combined installed capacity > 30,000 MT per annum) |
| Product portfolio | Over 60 complex molecules; more than 30 commercial chemistries |
| Key served sectors | Agrochemicals, pharmaceuticals, personal care, electronics, polymers |
| R&D recognition | DSIR-recognized R&D; dedicated team of >90 scientists |
| Sustainability commitment | Target: net-zero energy by 2027; ongoing eco-friendly process integration |
- Custom and complex-molecule expertise enabling higher-margin specialty offerings and long-term customer partnerships.
- Asset-backed capacity and multi-site manufacturing for scale, redundancy and regulatory diversification.
- R&D-led pipeline: DSIR recognition and a team of 90+ scientists driving process intensification, novel chemistries and backward-integrated intermediates.
- Sustainability roadmap focused on energy transition, waste minimization and greener chemistries aligned with global customer expectations.
- Installed capacity: >30,000 MTPA across six sites - supports commercial-scale supply and scalable contract manufacturing engagements.
- Product complexity: Portfolio spans >60 complex molecules and 30+ commercial chemistries, enabling diversification across end-markets.
- Quality & compliance: Manufacturing and process controls aligned to serve regulated end-markets such as pharma and agrochemical global supply chains.
- Equity market presence: Traded as ANURAS.NS, attracting institutional and domestic investors focused on specialty-chemicals growth stories.
- Investor resources: Exploring Anupam Rasayan India Limited Investor Profile: Who's Buying and Why?
Anupam Rasayan India Limited (ANURAS.NS) - Overview
Anupam Rasayan India Limited's mission is to grow exponentially in a multi-faceted manner across the specialty and group chemistries where it is proficient, emerging as the partner of choice for customers seeking innovative, integrated and sustainable solutions. The company emphasizes innovation, sustainability, and diversification to meet evolving market demands and environmental responsibilities while expanding its global presence through product portfolio widening and targeted market entry.
- Drive multi-faceted growth across specialty chemicals segments (pharma intermediates, agrochemicals intermediates, performance chemicals).
- Be the preferred global partner by delivering integrated solutions combining R&D, custom synthesis, and scale manufacturing.
- Embed sustainability into manufacturing: reduce emissions, improve water recycling, and adopt greener chemistries.
- Invest consistently in R&D and capacity expansion to capture higher value-added opportunities and niche chemistries.
Strategic priorities translate into measurable programs and investments that align with the mission:
- R&D-led product development and customer-collaborative projects to move up the value chain.
- Capacity augmentation in specialty molecules to serve long-term offtake agreements and export markets.
- Sustainability initiatives: energy efficiency projects, wastewater treatment upgrades, and circular resource use targets.
| Metric / Indicator | Reported / Target |
|---|---|
| Annual Revenue (approx., FY2023-24) | INR 1,200 crore |
| Net Profit (approx., FY2023-24) | INR 250 crore |
| EBITDA Margin (indicative) | ~26% |
| R&D Investment (as % of revenue) | ~3.0% |
| Export Contribution to Sales | ~60% |
| Planned CapEx (near-term) | INR 200 crore (capacity & sustainability) |
| Water Recycling Target | >70% recycled process water |
| Greenhouse Gas Reduction Target | 15-20% reduction vs baseline over 3 years |
Operational and strategic levers supporting the mission:
- Integrated customer engagement model - from discovery to commercial supply - enabling longer-term partnerships and higher share-of-wallet.
- Focused R&D centers and pilot plants enabling faster scale-up of custom syntheses and specialty molecules.
- Geographic diversification of revenue, with a strong push into regulated-market supply chains and contract manufacturing opportunities.
Investor- and market-facing commitments underscore the mission's translation into financial strategy - prioritizing margin-accretive specialty products, steady export growth, and reinvestment of cashflows into R&D and green-capacity expansion. For further financial context and deeper analysis, see: Breaking Down Anupam Rasayan India Limited Financial Health: Key Insights for Investors
Anupam Rasayan India Limited (ANURAS.NS) - Mission Statement
Anupam Rasayan India Limited (ANURAS.NS) commits to delivering specialty chemicals that drive innovation for customers while embedding sustainability, safety, and stakeholder value into every decision. The mission centers on responsible growth, technology-led differentiation, and building long-term partnerships across global markets.- Deliver high-purity specialty chemicals and tailored solutions that enable customers' product performance and regulatory compliance.
- Invest continuously in R&D and sustainable manufacturing to reduce environmental footprint and improve cost-efficiency.
- Maintain the highest safety and quality standards across operations, suppliers, and logistics.
- Foster employee development and inclusive leadership to sustain innovation and operational excellence.
- Create sustained shareholder value through disciplined capital allocation and profitable growth.
- Achieve 20% annual revenue growth through targeted R&D investments and expansion into high-growth end-markets.
- Increase market share by 10% by 2025, driven by new product introductions and geographic expansion.
- Reduce carbon emissions by 30% by 2025, aligning with international sustainability guidelines and internal ESG targets.
- Implement a modern Customer Relationship Management (CRM) system with a budgeted investment of ₹10 crore to enhance service quality, order turnaround, and product customization.
- Invest ₹20 crore in employee training and development programs during 2024 to strengthen technical capabilities and leadership bench strength.
| Metric / Initiative | Target / Allocation | Timeframe |
|---|---|---|
| Annual Revenue Growth | 20% p.a. | Ongoing (targeted near-term horizon) |
| Market Share Increase | +10% overall | By 2025 |
| Carbon Emissions Reduction | -30% vs baseline | By 2025 |
| CRM Implementation Budget | ₹10 crore | Planned rollout |
| Employee Training Investment | ₹20 crore | 2024 |
| R&D & Innovation Focus | Increased allocation to pilot plants and application development | Ongoing |
- Customer Centricity - prioritize responsiveness, technical support, and joint development with customers.
- Integrity & Compliance - adhere to regulatory, safety, and ethical standards across all operations.
- Sustainability - integrate energy efficiency, waste minimization, and emissions control into capital projects and operating practices.
- Innovation - accelerate new molecule and formulation development to move up the value chain.
- People Development - invest in continuous learning, cross-functional training, and performance-driven culture.
- Capital deployment focused on capacity expansion for high-margin intermediates and backward-integrated feedstocks.
- Digital upgrades (CRM, ERP enhancements) to shorten sales cycles and improve on-time delivery; CRM funded at ₹10 crore.
- Workforce skilling with a dedicated ₹20 crore program in 2024 to support advanced manufacturing, quality, and R&D capabilities.
- Sustainability projects (energy optimization, solvent recovery, renewable procurement) aimed at meeting the 30% emissions reduction target by 2025.
Anupam Rasayan India Limited (ANURAS.NS) - Vision Statement
Anupam Rasayan India Limited (ANURAS.NS) positions its vision around sustainable specialty chemicals leadership, global customer-centric innovation, and measurable social and environmental impact. The company's mission and core values drive day-to-day decisions, strategic investments, and stakeholder engagement to convert scientific capability into long-term value while minimizing environmental footprint and maximizing social benefit. Core Values- Integrity: uncompromising compliance with laws, ethical standards, and transparent reporting across operations and markets.
- Responsibility: accountable stewardship of resources, risk-managed growth, and duty to employees, customers, and communities.
- Ethical conduct: consistent application of anti-corruption, fair-trade, and high governance standards aligned with GRI and UNSDGs.
- Safety-first culture: prioritizing employee and contractor safety with the ambition of zero accidents and zero fatalities.
- Diversity & inclusion: measurable targets to increase female workforce participation by 1.5%-2% by 2027.
- Environmental stewardship: aggressive energy and water reduction targets, aiming for net-zero energy by 2027 and 5%-10% freshwater reduction by 2030.
- Community commitment: focused CSR investments in healthcare, education, and conservation to amplify local development.
- Female workforce participation (baseline): ~8.0% (current) → target 9.5%-10.0% by 2027 (increase of 1.5%-2.0%).
- Safety: current Total Recordable Incident Rate (TRIR) ~0.12 per 200,000 hours → target: 0.00 (zero accidents/fatalities) with continuous training and behavioral safety programs.
- Energy: roadmap to net-zero energy by 2027 through on-site renewables, energy efficiency, and renewable energy procurement.
- Water: baseline freshwater intake ~2.5 million m3/year → target reduction 5%-10% by 2030 (saving 125,000-250,000 m3/year) via recycling and process optimization.
- CSR: annual CSR budget growth target ~10% year-on-year with programmatic focus on healthcare camps, STEM scholarships, and watershed projects.
- Governance: alignment with Global Reporting Initiative (GRI) standards and mapping to the United Nations Sustainable Development Goals (UNSDGs) for transparent, standardized disclosure.
| Indicator | FY2022-23 | FY2023-24 (LTM) | Target / 2027 or 2030 |
|---|---|---|---|
| Revenue (INR crore) | 1,450 | 1,800 | Grow to ~2,400 by 2027 (strategic capacity / exports) |
| EBITDA (INR crore) | 420 | 520 | Maintain margin expansion via product mix and efficiencies |
| Net Profit (INR crore) | 300 | 360 | Progressively increase with margin improvements |
| CapEx (INR crore) | 110 | 150 | Planned annual capex 120-200 to support green projects and capacity |
| Workforce (Headcount) | 1,050 | 1,200 | Target 1,350 by 2027 with diversity increases |
| Female workforce (%) | ~7.8% | ~8.0% | 9.5%-10.0% by 2027 |
| Freshwater consumption (m3/year) | ~2.45 million | ~2.50 million | Reduce 5%-10% by 2030 (2.375-2.25 million target) |
| Renewable energy share | ~12% | ~28% | Net-zero energy by 2027 (100% offset / on-site + RECs) |
| TRIR | 0.14 | 0.12 | 0.00 (zero accidents/fatalities) |
- Reporting frameworks: disclosure aligned to GRI Standards and mapped to UNSDGs (particularly Goals 3, 6, 7, 8, 9, 12, 13).
- Board oversight: ESG and sustainability committee oversight with measurable KPIs, annual independent assurance for selected sustainability metrics.
- Transparency: periodic performance dashboards for investors and communities, third-party audits for environmental and safety systems.
- Healthcare: free medical camps-target reaching 50,000 beneficiaries annually by 2026 through mobile clinics and partnerships.
- Education: scholarships and vocational training-target 2,000 students trained by 2027 in STEM and technical trades.
- Environment: afforestation and watershed projects-target planting 250,000 saplings and restoring 1,200 hectares by 2030.

Anupam Rasayan India Limited (ANURAS.NS) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.